Norway
· Delayed Price · Currency is NOK Gentian Diagnostics ASA Statistics
Total Valuation
Gentian Diagnostics ASA has a market cap or net worth of NOK 771.12 million. The enterprise value is 697.87 million.
| Market Cap | 771.12M |
| Enterprise Value | 697.87M |
Important Dates
The last earnings date was Thursday, August 29, 2024.
| Earnings Date | Aug 29, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Gentian Diagnostics ASA has 15.42 million shares outstanding. The number of shares has decreased by -0.31% in one year.
| Shares Outstanding | 15.42M |
| Shares Change (YoY) | -0.31% |
| Shares Change (QoQ) | +2.28% |
| Owned by Insiders (%) | 10.12% |
| Owned by Institutions (%) | 23.37% |
| Float | 6.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 116.99 |
| PS Ratio | 5.07 |
| PB Ratio | 4.85 |
| P/FCF Ratio | 67.45 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 80.16, with an EV/FCF ratio of 61.04.
| EV / Earnings | -347.54 |
| EV / Sales | 4.61 |
| EV / EBITDA | 80.16 |
| EV / EBIT | 276.71 |
| EV / FCF | 61.04 |
Financial Position
The company has a current ratio of 6.73, with a Debt / Equity ratio of 4.94.
| Current Ratio | 6.73 |
| Quick Ratio | 4.83 |
| Debt / Equity | 4.94 |
| Debt / EBITDA | 0.89 |
| Debt / FCF | 0.68 |
| Interest Coverage | 1.95 |
Financial Efficiency
Return on equity (ROE) is -1.28% and return on invested capital (ROIC) is 0.95%.
| Return on Equity (ROE) | -1.28% |
| Return on Assets (ROA) | 0.84% |
| Return on Capital (ROIC) | 0.95% |
| Revenue Per Employee | 2.61M |
| Profits Per Employee | -34,621 |
| Employee Count | 58 |
| Asset Turnover | 0.80 |
| Inventory Turnover | 1.69 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +17.10% in the last 52 weeks. The beta is 0.60, so Gentian Diagnostics ASA's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | +17.10% |
| 50-Day Moving Average | 54.38 |
| 200-Day Moving Average | 43.71 |
| Relative Strength Index (RSI) | 28.00 |
| Average Volume (20 Days) | 5,212 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Gentian Diagnostics ASA had revenue of NOK 151.51 million and -2.01 million in losses. Loss per share was -0.13.
| Revenue | 151.51M |
| Gross Profit | 80.94M |
| Operating Income | 2.52M |
| Pretax Income | -1.73M |
| Net Income | -2.01M |
| EBITDA | 5.08M |
| EBIT | 2.52M |
| Loss Per Share | -0.13 |
Balance Sheet
The company has 81.02 million in cash and 7.77 million in debt, giving a net cash position of 73.25 million or 4.75 per share.
| Cash & Cash Equivalents | 81.02M |
| Total Debt | 7.77M |
| Net Cash | 73.25M |
| Net Cash Per Share | 4.75 |
| Equity (Book Value) | 157.38M |
| Book Value Per Share | 10.31 |
| Working Capital | 124.12M |
Cash Flow
In the last 12 months, operating cash flow was 12.74 million and capital expenditures -1.31 million, giving a free cash flow of 11.43 million.
| Operating Cash Flow | 12.74M |
| Capital Expenditures | -1.31M |
| Free Cash Flow | 11.43M |
| FCF Per Share | 0.74 |
Margins
Gross margin is 53.42%, with operating and profit margins of 1.66% and -1.33%.
| Gross Margin | 53.42% |
| Operating Margin | 1.66% |
| Pretax Margin | -1.14% |
| Profit Margin | -1.33% |
| EBITDA Margin | 3.35% |
| EBIT Margin | 1.66% |
| FCF Margin | 7.55% |
Dividends & Yields
Gentian Diagnostics ASA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.31% |
| Shareholder Yield | 0.31% |
| Earnings Yield | -0.27% |
| FCF Yield | 1.48% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |